RSS feed

Publications (original articles or review articles) published in 2023 from OUS - Rheumatology Research Group

38 publications found

Ali AM, Yakupoglu HY, Fuchs TA, Larsen TH, Aukrust P, Gunnarsson R, Saeed S (2023)
Cardiac Involvement in Systemic and Local Vasculitides: The Value of Noninvasive Multimodality Imaging
Curr Probl Cardiol, 48 (8), 101718
DOI 10.1016/j.cpcardiol.2023.101718, PubMed 37003450

Allanore Y, Khanna D, Smith V, Aringer M, Hoffmann-Vold AM, Kuwana M, Merkel PA, Stock C, Sambevski S, Denton CP, SENSCIS trial investigators (2023)
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/kead280, PubMed 37294870

Berger SG, Witczak BN, Reiseter S, Schwartz T, Andersson H, Hetlevik SO, Berntsen KS, Sanner H, Lilleby V, Gunnarsson R, Molberg Ø, Sjaastad I, Stokke MK (2023)
Cardiac dysfunction in mixed connective tissue disease: a nationwide observational study
Rheumatol Int, 43 (6), 1055-1065
DOI 10.1007/s00296-023-05308-3, PubMed 36933069

Boleto G, Reiseter S, Hoffmann-Vold AM, Mirouse A, Cacoub P, Matucci-Cerinic M, Silvério-António M, Fonseca JE, Duarte AC, Pestana Lopes J, Riccieri V, Lescoat A, Le Tallec E, Castellví Barranco I, Tandaipan JL, Airó P, Kuwana M, Kavosi H, Avouac J, Allanore Y (2023)
The phenotype of mixed connective tissue disease patients having associated interstitial lung disease
Semin Arthritis Rheum, 63, 152258 (in press)
DOI 10.1016/j.semarthrit.2023.152258, PubMed 37696231

Bull Haaversen AC, Brekke LK, Kermani TA, Molberg Ø, Diamantopoulos AP (2023)
Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis
Rheumatology (Oxford), 62 (5), 1887-1894
DOI 10.1093/rheumatology/keac478, PubMed 35997556

Campochiaro C, Hoffmann-Vold AM, Avouac J, Henes J, de Vries-Bouwstra J, Smith V, Siegert E, Airò P, Oksel F, Pellerito R, Vanthuyne M, Pozzi MR, Inanc M, Sibilia J, Gabrielli A, Distler O, Allanore Y, EUSTAR Collaborators (2023)
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis
Rheumatology (Oxford), 62 (7), 2483-2491
DOI 10.1093/rheumatology/keac660, PubMed 36413079

Colalillo A, Hoffmann-Vold AM, Pellicano C, Romaniello A, Gabrielli A, Hachulla E, Smith V, Simeón-Aznar CP, Castellví I, Airò P, Truchetet ME, Siegert E, Distler O, Rosato E, EUSTAR collaborators (2023)
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort
Autoimmun Rev, 22 (4), 103290
DOI 10.1016/j.autrev.2023.103290, PubMed 36746368

Collado P, Martire MV, Lanni S, De Lucia O, Balint P, Guillaume-Czitrom S, Hernandez-Diaz C, Sande NK, Magni-Manzoni S, Malattia C, Rossi-Semerano L, Roth J, Ting T, Vega-Fernandez P, Windschall D, D'Agostino MA, Naredo E, OMERACT Ultrasound Group (2023)
OMERACT International Consensus for Ultrasound Definitions of Tenosynovitis in Juvenile Idiopathic Arthritis: Systematic Literature Review and Delphi Process
Arthritis Care Res (Hoboken), 75 (11), 2277-2284
DOI 10.1002/acr.25159, PubMed 37221153

Damrath M, Veletic M, Rudsari HK, Balasingham I (2023)
Optimization of Extracellular Vesicle Release for Targeted Drug Delivery
IEEE Trans Nanobioscience, PP (in press)
DOI 10.1109/TNB.2023.3287637, PubMed 37335787

Deibel E, Carreira PE, Vonk M, Del Papa N, Bečvář R, Guillén-Del-Castillo A, Campochiaro C, Poormoghim H, Liem S, Lazzaroni MG, Giollo A, Mekinian A, de Vries-Bouwstra J, De Santis M, Balbir-Gurman A, Mihai C, De Luca G, Moiseev S, Zanatta E, Foti R, Rednic S, Denton C, Cutolo M, Belloli L, Airo P et al. (2023)
Does the impact of COVID-19 on patients with systemic sclerosis change over time?
Arthritis Care Res (Hoboken) (in press)
DOI 10.1002/acr.25226, PubMed 37667424

Ekman D, Sennblad B, Knight A, Karlsson Å, Rantapää-Dahlqvist S, Berglin E, Stegmayr B, Baslund B, Palm Ø, Haukeland H, Gunnarsson I, Bruchfeld A, Segelmark M, Ohlsson S, Mohammad AJ, Svärd A, Pullerits R, Herlitz H, Söderbergh A, Omdal R, Jonsson R, Rönnblom L, Eriksson P, Lindblad-Toh K, Dahlqvist J (2023)
Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis
Rheumatology (Oxford), 62 (9), 3213-3218
DOI 10.1093/rheumatology/kead152, PubMed 37004177

Garaiman A, Steigmiller K, Gebhard C, Mihai C, Dobrota R, Bruni C, Matucci-Cerinic M, Henes J, de Vries-Bouwstra J, Smith V, Doria A, Allanore Y, Dagna L, Anić B, Montecucco C, Kowal-Bielecka O, Martin M, Tanaka Y, Hoffmann-Vold AM, Held U, Distler O, Becker MO, EUSTAR Collaborators (2023)
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model
Rheumatology (Oxford), 62 (SI), SI91-SI100
DOI 10.1093/rheumatology/keac405, PubMed 35904554

Gegenava T, Fortuni F, van Leeuwen NM, Tennoe AH, Hoffmann-Vold AM, Jurcut R, Giuca A, Groseanu L, Tanner F, Distler O, Bax JJ, De Vries-Bouwstra J, Ajmone Marsan N (2023)
Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
RMD Open, 9 (4)
DOI 10.1136/rmdopen-2023-003380, PubMed 37949614

Guler S, Sarbu AC, Stalder O, Allanore Y, Bernardino V, Distler J, Gabrielli A, Hoffmann-Vold AM, Matucci-Cerinic M, Müller-Ladner U, Ortiz-Santamaria V, Rednic S, Riccieri V, Smith V, Ullman S, Walker UA, Geiser TK, Distler O, Maurer B, Kollert F (2023)
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis
Thorax, 78 (12), 1188-1196
DOI 10.1136/thorax-2023-220541, PubMed 37798114

Hedenstedt A, Reid S, Sayadi A, Eloranta ML, Skoglund E, Bolin K, Frodlund M, Lerang K, Jönsen A, Rantapää-Dahlqvist S, Bengtsson AA, Rudin A, Molberg Ø, Sjöwall C, Sandling JK, Leonard D (2023)
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus
Lupus Sci Med, 10 (2)
DOI 10.1136/lupus-2023-000926, PubMed 37844960

Hestetun S, Andersen S, Sanner H, Størdal K (2023)
Antibiotic exposure in prenatal and early life and risk of juvenile idiopathic arthritis: a nationwide register-based cohort study
RMD Open, 9 (3)
DOI 10.1136/rmdopen-2023-003333, PubMed 37648397

Hughes M, Huang S, Alegre-Sancho JJ, Carreira PE, Engelhart M, Hachulla E, Henes J, Kerzberg E, Pozzi MR, Riemekasten G, Smith V, Szücs G, Vanthuyne M, Zanatta E, Distler O, Gabrielli AG, Hoffmann-Vold AM, Steen VD, Khanna D, EUSTAR Collaborators (2023)
Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort
Rheumatology (Oxford), 62 (SI), SI54-SI63
DOI 10.1093/rheumatology/keac363, PubMed 35731139

Hum RM, Lilleker JB, Lamb JA, Oldroyd AGS, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Danieli MG, Oakley P, Griger Z, Phuong TNT, Kodishala C, Vazquez-Del Mercado M, Andersson H, De Paepe B, De Bleecker JL, Maurer B, McCann L, Pipitone N, McHugh N, New RP, Ollier WE, Krogh NS, Vencovsky J et al. (2023)
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: Results from the MYONET registry
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/kead481, PubMed 37698987

Iudici M, Mongin D, Siegert E, Carreira PE, Distler J, Henes J, Zanatta E, Hachulla E, De Luca G, de Souza Müller C, Santiago T, Tandaipan JL, Valdetaro Bianchi B, De Santis M, Hoffmann-Vold AM, Gabrielli A, Distler O, Courvoisier DS, EUSTAR collaborators (2023)
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database
Rheumatology (Oxford), 62 (4), 1559-1567
DOI 10.1093/rheumatology/keac533, PubMed 36099040

Jones S, Flewett M, Flewett R, Lee S, Vick B, Thompson M, Pinnetti S, Zoz DF, Hoffmann-Vold AM, Kreuter M, Maher TM (2023)
Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations
ERJ Open Res, 9 (3)
DOI 10.1183/23120541.00602-2022, PubMed 37260456

Khanna D, Maher TM, Volkmann ER, Allanore Y, Smith V, Assassi S, Kreuter M, Hoffmann-Vold AM, Kuwana M, Stock C, Alves M, Sambevski S, Denton CP (2023)
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002859, PubMed 36796874

Kim H, Saygin D, Douglas C, Wilkerson J, Erman B, Pistorio A, McGrath JA, Reed AM, Oddis CV, Bracaglia C, van Royen-Kerkhof A, Bica B, Dolezalova P, Ferriani VPL, Flato B, Bernard-Medina AG, Herlin T, Miller FW, Vencovsky J, Ruperto N, Aggarwal R, Rider LG, International Myositis Assessment and Clinical Studies Group (IMACS) and Paediatric Rheumatology INternational Trials Organization (PRINTO) (2023)
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles
Rheumatology (Oxford), 62 (11), 3680-3689
DOI 10.1093/rheumatology/kead111, PubMed 36929918

Kreuter M, Hoffmann-Vold AM, Matucci-Cerinic M, Saketkoo LA, Highland KB, Wilson H, Alves M, Erhardt E, Schoof N, Maher TM (2023)
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease
Rheumatology (Oxford), 62 (SI), SI43-SI53
DOI 10.1093/rheumatology/keac325, PubMed 35640959

Leclair V, Galindo-Feria AS, Rothwell S, Kryštůfková O, Zargar SS, Mann H, Diederichsen LP, Andersson H, Klein M, Tansley S, Rönnblom L, Lindblad-Toh K, Syvänen AC, Wahren-Herlenius M, Sandling JK, Dissect Consortium and The Immunoarray Development Consortium, McHugh N, Lamb JA, Vencovský J, Chinoy H, Holmqvist M, Bianchi M, Padyukov L, Lundberg IE, Diaz-Gallo LM (2023)
Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
EBioMedicine, 96, 104804
DOI 10.1016/j.ebiom.2023.104804, PubMed 37769433

Lescoat A, Huang S, Carreira PE, Siegert E, de Vries-Bouwstra J, Distler JHW, Smith V, Del Galdo F, Anic B, Damjanov N, Rednic S, Ribi C, Bancel DF, Hoffmann-Vold AM, Gabrielli A, Distler O, Khanna D, Allanore Y, EUSTAR collaborators (2023)
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database
JAMA Dermatol, 159 (8), 837-847
DOI 10.1001/jamadermatol.2023.1729, PubMed 37378994

Lescoat A, Huscher D, Schoof N, Airò P, de Vries-Bouwstra J, Riemekasten G, Hachulla E, Doria A, Rosato E, Hunzelmann N, Montecucco C, Gabrielli A, Hoffmann-Vold AM, Distler O, Ben Shimol J, Cutolo M, Allanore Y, (2023)
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Rheumatology (Oxford), 62 (6), 2178-2188
DOI 10.1093/rheumatology/keac576, PubMed 36222557

Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Coeck C, Schlecker C, Voss F, Wachtlin D, Martinez FJ (2023)
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)
BMJ Open Respir Res, 10 (1)
DOI 10.1136/bmjresp-2022-001580, PubMed 37709661

Marstein HS, Witczak BN, Godang K, Olarescu NC, Schwartz T, Flatø B, Molberg Ø, Bollerslev J, Sjaastad I, Sanner H (2023)
Adipokine profile in long-term juvenile dermatomyositis, and associations with adipose tissue distribution and cardiac function: a cross-sectional study
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002815, PubMed 36828644

Marstein HS, Witczak BN, Godang K, Schwartz T, Flatø B, Bollerslev J, Sjaastad I, Sanner H (2023)
Adipose tissue distribution is associated with cardio-metabolic alterations in adult patients with juvenile-onset dermatomyositis
Rheumatology (Oxford), 62 (SI2), SI196-SI204
DOI 10.1093/rheumatology/keac293, PubMed 35575380

Moe SR, Haukeland H, Brunborg C, Botea A, Damjanic N, Wivestad GÅ, Øvreås H, Bøe T, Orre A, Garen T, Lilleby V, Provan SA, Molberg Ø, Lerang K (2023)
Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/kead519, PubMed 37769251

Rezaei M, Rudsari HK, Javan M, Mokari N, Jorswieck EA, Orooji M (2023)
Molecular Communication Transmitter Design in Limited-Capacity Storage Regime
IEEE Trans Nanobioscience, 22 (2), 212-222
DOI 10.1109/TNB.2022.3179317, PubMed 35635824

Rothwell S, Amos CI, Miller FW, Rider LG, Lundberg IE, Gregersen PK, Vencovsky J, McHugh N, Limaye V, Selva-O'Callaghan A, Hanna MG, Machado PM, Pachman LM, Reed AM, Molberg Ø, Benveniste O, Mathiesen P, Radstake T, Doria A, De Bleecker JL, De Paepe B, Maurer B, Ollier WE, Padyukov L, O'Hanlon TP et al. (2023)
Identification of Novel Associations and Localization of Signals in Idiopathic Inflammatory Myopathies Using Genome-Wide Imputation
Arthritis Rheumatol, 75 (6), 1021-1027
DOI 10.1002/art.42434, PubMed 36580032

Sande NK, Lilleby V, Aga AB, Kirkhus E, Flatø B, Bøyesen P (2023)
Associations between power Doppler ultrasound findings and B-mode synovitis and clinical arthritis in juvenile idiopathic arthritis using a standardised scanning approach and scoring system
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002937, PubMed 36963783

Strahm N, Didriksen H, Fretheim H, Molberg Ø, Midtvedt Ø, Farstad IN, Midtvedt T, Lundin KEA, Aabakken L, Błyszczuk P, Distler O, Kania G, Hoffmann-Vold AM (2023)
Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis
Rheumatology (Oxford), 62 (8), 2918-2929
DOI 10.1093/rheumatology/kead014, PubMed 36688692

Vikse J, Midtvedt Ø, Fevang BS, Garen T, Palm Ø, Wallenius M, Bakland G, Norheim KB, Molberg Ø, Hoffmann-Vold AM (2023)
Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
Arthritis Res Ther, 25 (1), 163
DOI 10.1186/s13075-023-03155-y, PubMed 37670401

Volkmann ER, Sparks JA, Hoffmann-Vold AM, Doyle TJ, Emery P, Dieudé P (2023)
Preclinical/subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences
Lancet Rheumatol, 5 (3), e116-e118
DOI 10.1016/s2665-9913(23)00033-4, PubMed 37701927

Vonk MC, Assassi S, Hoffmann-Vold AM (2023)
Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?
Rheum Dis Clin North Am, 49 (2), 249-262
DOI 10.1016/j.rdc.2023.01.003, PubMed 37028833

Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C et al. (2023)
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Ann Rheum Dis, 82 (10), 1286-1295
DOI 10.1136/ard-2023-224116, PubMed 37423647